- Reported transaction lines
- 2
- Buy lines
- 2
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-112
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Salovey Peter Director · Legend Biotech Corp | LEGN Legend Biotech Corp | BuyFiling detailsSEC transaction code P Ordinary Shares · Direct ownership · Reported balance after transaction: 75096 · SEC code covers open-market or private transactions · The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer. · The price reported in Column 4 represents the converted purchase price of the ADSs of $17.90 per ADS. | 2026-11-13 | 2026-11-16 | ≈ $89,500.00 10,000 shares/units | SEC 4 |
| Salovey Peter Director · Legend Biotech Corp | LEGN Legend Biotech Corp | BuyFiling detailsSEC transaction code P Ordinary Shares · Direct ownership · Reported balance after transaction: 65096 · SEC code covers open-market or private transactions · The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer. · The price reported in Column 4 represents the converted purchase price of the ADSs of $18.75 per ADS. | 2026-11-12 | 2026-11-16 | ≈ $93,750.00 10,000 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.